Injectable GHK-Cu is not an approved medicine
Reduces Appetite: With peptides like GLP-1, youll feel less hungry, making it easier to follow a calorie-controlled diet and reduce overall calorie intake without the need for restrictive diets
The 0.25 mg starter is pharmacologically active
Which reader are you Three profiles, because the right answer is not the same for everyone
This includes people with: Pernicious anaemia (autoimmune destruction of intrinsic factor-producing cells), typically requiring lifelong IM injections Crohn's disease or surgical resection affecting the terminal ileum Coeliac disease causing malabsorption (may improve with gluten-free diet) Chronic pancreatitis reducing enzyme availability needed for B12 release Vegans and strict vegetarians need reliable B12 sources through fortified foods or supplements, as plant-based diets contain negligible amounts of active B12

The phase 1b and phase 2 clinical trials have only recently been completed: Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: a randomised, controlled, phase 1b trial and Promising phase 2 results for long-acting amylin analog cagrilintide diabetes.medicinematters.com Medicine Matters diabetes is a resource for healthcare professionals seeking credible information on the diagnosis, management and prevention of diabetes